Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
E2F7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
COCH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NR2F2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HTR2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM169A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPM6B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLXND1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPCAM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100509457 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
KCNJ4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC6A15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCCPDH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAPTM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POMT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTPRN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RIMS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP53 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALPK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DIP2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on